Refinement of the solution structure and dynamic properties of Ca(2+)-bound rat S100B.
作者信息
Wright Nathan T, Inman Keith G, Levine Jonathan A, Cannon Brian R, Varney Kristen M, Weber David J
机构信息
Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
出版信息
J Biomol NMR. 2008 Dec;42(4):279-86. doi: 10.1007/s10858-008-9282-y. Epub 2008 Oct 24.
Abstract
摘要
相似文献
1
Refinement of the solution structure and dynamic properties of Ca(2+)-bound rat S100B.钙离子结合的大鼠S100B蛋白溶液结构及动力学性质的优化
J Biomol NMR. 2008 Dec;42(4):279-86. doi: 10.1007/s10858-008-9282-y. Epub 2008 Oct 24.
2
Solution NMR structure of S100B bound to the high-affinity target peptide TRTK-12.与高亲和力靶肽TRTK-12结合的S100B的溶液核磁共振结构。
J Mol Biol. 2002 Dec 13;324(5):1003-14. doi: 10.1016/s0022-2836(02)01152-x.
3
Location of the Zn(2+)-binding site on S100B as determined by NMR spectroscopy and site-directed mutagenesis.通过核磁共振光谱和定点诱变确定S100B上锌离子结合位点的位置。
Biochemistry. 2003 Nov 25;42(46):13410-21. doi: 10.1021/bi035334q.
4
The effects of CapZ peptide (TRTK-12) binding to S100B-Ca2+ as examined by NMR and X-ray crystallography.通过 NMR 和 X 射线晶体学研究 CapZ 肽（TRTK-12）与 S100B-Ca2+ 的结合作用。
J Mol Biol. 2010 Mar 12;396(5):1227-43. doi: 10.1016/j.jmb.2009.12.057. Epub 2010 Jan 4.
5
Solution structure of zinc- and calcium-bound rat S100B as determined by nuclear magnetic resonance spectroscopy.通过核磁共振光谱法测定的锌和钙结合的大鼠S100B的溶液结构。
Biochemistry. 2005 Apr 19;44(15):5690-702. doi: 10.1021/bi0475830.
6
Small molecules bound to unique sites in the target protein binding cleft of calcium-bound S100B as characterized by nuclear magnetic resonance and X-ray crystallography.小分子与钙结合的S100B靶蛋白结合裂隙中的独特位点结合，这是通过核磁共振和X射线晶体学表征的。
Biochemistry. 2009 Jul 7;48(26):6202-12. doi: 10.1021/bi9005754.
7
Target binding to S100B reduces dynamic properties and increases Ca(2+)-binding affinity for wild type and EF-hand mutant proteins.S100B 的靶向结合降低了野生型和 EF 手突变蛋白的动态特性，并增加了其与 Ca(2+)的结合亲和力。
J Mol Biol. 2012 Oct 26;423(3):365-85. doi: 10.1016/j.jmb.2012.07.011. Epub 2012 Jul 21.
8
A novel S100 target conformation is revealed by the solution structure of the Ca2+-S100B-TRTK-12 complex.Ca2+-S100B-TRTK-12复合物的溶液结构揭示了一种新型的S100靶标构象。
J Biol Chem. 2003 Feb 21;278(8):6251-7. doi: 10.1074/jbc.M210622200. Epub 2002 Dec 11.
9
Structure of the Ca2+/S100B/NDR kinase peptide complex: insights into S100 target specificity and activation of the kinase.钙离子/ S100B蛋白/ NDR激酶肽复合物的结构：对S100靶标特异性及激酶激活的见解
Biochemistry. 2003 Dec 16;42(49):14416-26. doi: 10.1021/bi035089a.
10
Divalent metal ion complexes of S100B in the absence and presence of pentamidine.在有和没有喷他脒的情况下，S100B的二价金属离子络合物
J Mol Biol. 2008 Sep 26;382(1):56-73. doi: 10.1016/j.jmb.2008.06.047. Epub 2008 Jun 24.
引用本文的文献
1
Binding and Functional Folding (BFF): A Physiological Framework for Studying Biomolecular Interactions and Allostery.结合与功能折叠（BFF）：研究生物分子相互作用和变构的生理框架。
J Mol Biol. 2022 Dec 15;434(23):167872. doi: 10.1016/j.jmb.2022.167872. Epub 2022 Oct 28.
2
Calcium-Dependent Translocation of S100B Is Facilitated by Neurocalcin Delta.钙依赖性 S100B 易位由神经钙蛋白 δ 促进。
Molecules. 2021 Jan 5;26(1):227. doi: 10.3390/molecules26010227.
3
Ca(II) and Zn(II) Cooperate To Modulate the Structure and Self-Assembly of S100A12.钙（II）和锌（II）协同调节 S100A12 的结构和自组装。
Biochemistry. 2019 Apr 30;58(17):2269-2281. doi: 10.1021/acs.biochem.9b00123. Epub 2019 Apr 18.
4
X-ray crystal structure of human calcium-bound S100A1.人钙结合型S100A1的X射线晶体结构
Acta Crystallogr F Struct Biol Commun. 2017 Apr 1;73(Pt 4):215-221. doi: 10.1107/S2053230X17003983. Epub 2017 Mar 22.
5
Structure of the small Dictyostelium discoideum myosin light chain MlcB provides insights into MyoB IQ motif recognition.小盘基网柄菌肌球蛋白轻链MlcB的结构为了解肌球蛋白B的IQ模体识别提供了线索。
J Biol Chem. 2014 Jun 13;289(24):17030-42. doi: 10.1074/jbc.M113.536532. Epub 2014 May 1.
6
Structure of the S100A4/myosin-IIA complex.S100A4/肌球蛋白-IIA复合物的结构。
BMC Struct Biol. 2013 Nov 20;13:31. doi: 10.1186/1472-6807-13-31.
7
Novel interactions of the TRTK12 peptide with S100 protein family members: specificity and thermodynamic characterization.TRTK12 肽与 S100 蛋白家族成员的新型相互作用：特异性和热力学特征。
Biochemistry. 2013 Aug 27;52(34):5844-56. doi: 10.1021/bi400788s. Epub 2013 Aug 15.
8
The evolution of S100B inhibitors for the treatment of malignant melanoma.S100B 抑制剂治疗恶性黑色素瘤的研究进展。
Future Med Chem. 2013 Jan;5(1):97-109. doi: 10.4155/fmc.12.191.
9
Post-translational S-nitrosylation is an endogenous factor fine tuning the properties of human S100A1 protein.翻译后修饰的S-亚硝基化是一种对人类S100A1蛋白特性进行微调的内源性因素。
J Biol Chem. 2012 Nov 23;287(48):40457-70. doi: 10.1074/jbc.M112.418392. Epub 2012 Sep 18.
10
Target binding to S100B reduces dynamic properties and increases Ca(2+)-binding affinity for wild type and EF-hand mutant proteins.S100B 的靶向结合降低了野生型和 EF 手突变蛋白的动态特性，并增加了其与 Ca(2+)的结合亲和力。
J Mol Biol. 2012 Oct 26;423(3):365-85. doi: 10.1016/j.jmb.2012.07.011. Epub 2012 Jul 21.
本文引用的文献
1
S100A1 and calmodulin compete for the same binding site on ryanodine receptor.S100A1与钙调蛋白竞争兰尼碱受体上的同一结合位点。
J Biol Chem. 2008 Sep 26;283(39):26676-83. doi: 10.1074/jbc.M804432200. Epub 2008 Jul 23.
2
Divalent metal ion complexes of S100B in the absence and presence of pentamidine.在有和没有喷他脒的情况下，S100B的二价金属离子络合物
J Mol Biol. 2008 Sep 26;382(1):56-73. doi: 10.1016/j.jmb.2008.06.047. Epub 2008 Jun 24.
3
Pathologies involving the S100 proteins and RAGE.涉及S100蛋白和晚期糖基化终末产物受体的病理学
Subcell Biochem. 2007;45:93-138. doi: 10.1007/978-1-4020-6191-2_5.
4
A review of the S100 proteins in cancer.癌症中S100蛋白的综述。
Eur J Surg Oncol. 2008 Apr;34(4):357-64. doi: 10.1016/j.ejso.2007.04.009. Epub 2007 Jun 13.
5
Recognition of the tumor suppressor protein p53 and other protein targets by the calcium-binding protein S100B.钙结合蛋白S100B对肿瘤抑制蛋白p53及其他蛋白质靶点的识别。
Biochim Biophys Acta. 2006 Nov;1763(11):1284-97. doi: 10.1016/j.bbamcr.2006.08.024. Epub 2006 Aug 25.
6
The three-dimensional solution structure of Ca(2+)-bound S100A1 as determined by NMR spectroscopy.通过核磁共振光谱法测定的钙离子结合型S100A1的三维溶液结构。
J Mol Biol. 2005 Oct 21;353(2):410-26. doi: 10.1016/j.jmb.2005.08.027.
7
Calcium-binding properties of wild-type and EF-hand mutants of S100B in the presence and absence of a peptide derived from the C-terminal negative regulatory domain of p53.在存在和不存在源自p53 C末端负调控域的肽的情况下，S100B野生型和EF手型突变体的钙结合特性。
Biochemistry. 2005 May 17;44(19):7305-14. doi: 10.1021/bi050321t.
8
Inhibiting S100B restores p53 levels in primary malignant melanoma cancer cells.抑制S100B可恢复原发性恶性黑色素瘤癌细胞中的p53水平。
J Biol Chem. 2004 Aug 6;279(32):34071-7. doi: 10.1074/jbc.M405419200. Epub 2004 Jun 3.
9
Solution NMR structure of S100B bound to the high-affinity target peptide TRTK-12.与高亲和力靶肽TRTK-12结合的S100B的溶液核磁共振结构。
J Mol Biol. 2002 Dec 13;324(5):1003-14. doi: 10.1016/s0022-2836(02)01152-x.
10
A structural basis for S100 protein specificity derived from comparative analysis of apo and Ca(2+)-calcyclin.基于脱辅基蛋白和钙调蛋白的比较分析得出的S100蛋白特异性的结构基础。
J Mol Biol. 2002 Mar 22;317(2):279-90. doi: 10.1006/jmbi.2002.5421.
Zotero 插件